Use of sacubitril/valsartan early after CABG.

Madina NurzhanovaAisulu MusagaliyevaRaushan ZhakypovaDaniya SenkibayevaAmina Rakisheva

Published in: Open heart (2024)

The early initiation of sacubitril/valsartan in patients after CABG with HFrEF is safe and effective. Adverse events and permanent discontinuation were low. The NT-proBNP concentration reduced significantly with the early in-hospital initiation.

Keyphrases

ejection fraction
end stage renal disease
chronic kidney disease
coronary artery bypass grafting
healthcare
newly diagnosed
emergency department
prognostic factors
atrial fibrillation